(1 - 14 von 22
)
PDE-5 inhibitors linked to prostate cancer biochemical recurrence ...www.oncologynurseadvisor.com › home › headlines
www.oncologynurseadvisor.com
· Uwe Michl, from University Hospital Hamburg-Eppendorf in Germany, and colleagues examined the effect of phosphodiesterase type
sortiert nach Relevanz / Datum